New York S 5439: Designates Xylazine as a schedule III depressant

Status: REFERRED TO HEALTH (as of 2024-01-03)

State: New York · Session: 2023-2024 · Bill: S 5439

Sponsors: James Skoufis

View New York S 5439 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.